
دبالک
مواد اولیه دارویی البرز بالک
Adjusted Price Chart of دبالک and دبالک Signal Trend
سود 3 Months :
Traders' comments on price دبالک
Who made the most profit from دبالک?
سیگنالهای دبالک
Filter
Signal Type
Trader Type
Time Frame
نوع پیام

شرکت سرمایه گذاری البرز
Alborz Investment Company bought 0.527 million shares on 14/04/31 and currently accounts for 44.226 % of Debbak's shares in its portfolio.
#Dallek Explanations on information and #Memicituals published by #Price_Maine_Abi_Albarz_Labak Regarding the announcement issued by the follow -up number 1372923 on 14/04/30, the increase in the company's operating profit compared to the same period of the previous fiscal year is present. 1404-04-31 15:02:42 (1377967) ایرین ایرین @codal360_ir

مانا بورس
و Iran's injectable and pharmaceutical products in the spring, with the sale of 2 billion tomans, increased by 5 % over the same period last year. This growth, with the improvement of the profit margin, with a net profit of 2 billion tomans, was 2 percent. The net profit of the year was 2 billion tomans, which has been able to realize 2 % in one season in the spring of Dafra. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Dafra #Medicine 📱@Fardaname

بورس طارم
و Iran's injectable and pharmaceutical products in the spring, with the sale of 2 billion tomans, increased by 5 % over the same period last year. This growth, with the improvement of the profit margin, with a net profit of 2 billion tomans, was 2 percent. The net profit of the year was 2 billion tomans, which has been able to realize 2 % in one season in the spring of Dafra. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Dafra #Medicine 📱@Fardaname

بورس طارم
The drug made 2.5 times as much as last spring This year's spring report shows that the company has managed to increase gross profit by 5 % as sales increased by 5 % compared to the same period last year. The company, which had announced 2 billion tomans last spring, has increased this number to 5 billion tomans this year. The total net profit was 2 billion tomans. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Medication #Medication 📱 @fardaname

بورس طارم
ان Disagreevi was revived Zahravi's pharmacy, which had spent many years in 1 and 2, reported 2 billion tomans and 2 billion tomans of net profit last year. December this year has announced 2 billion tomans of profits, which is a 5 percent increase over the same period last year. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Delimravi #Pharmaceutical 📱 @fardaname

صبر سبز 🌿
#Dalk Information and #More_Manic Failures #Courses_6_Maine to 1404/03/31 (Uncaters) ▪️ Alborz Balk Raw Materials Company has identified 224 riyals per share of 224 riyals per share, which is 195 % compared to the same period last year. ▪️ Debak with a registered capital of 1,820,000 million Rials in the six -month performance ending to 140/03/31 has identified 407,197 million rials. @talarehafez
#Dallek #Disclosure_Hight_Hight - (Disclosure of Transactions Subject to Article 129 of the Business Law or other affiliated persons - Group b) ended in fiscal year 1404/09/30 Company #Mad_Awali_Deval_Albarz_Leak 1404-04-30 18:24:23 (1376804) ایرین ایرین @codal360_ir
#Dallek Information and #More_Manic Failures #Courses_6_Maine to 1404/03/31 (Uncaters) ▪️ Alborz Balk Raw Materials Company has identified 224 riyals per share of 224 riyals per share, which is 195 % compared to the same period last year. ▪️ Debak with a registered capital of 1,820,000 million Rials in the six -month performance ending to 140/03/31 has identified 407,197 million rials. 1404-04-30 15:02:24 (1372923) ایرین ایرین @codal360_ir

•𝑩𝑶𝑼𝑹𝑺~ 𝑺𝑲𝒀•
# #Disagne was revived Zahravi's pharmacy, which had spent many years in 1 and 2, reported 2 billion tomans and 2 billion tomans of net profit last year. December this year has announced 2 billion tomans of profits, which is a 5 percent increase over the same period last year. According to a comparison between June and spring sales report and the same period last year and winter, the symbols of #Defra #Drug #Dulbar #Caspian #Dabor #Danco #Danco and #Dabid, show the greatest monthly sales increase compared to their past times. #Delimravi #Pharmaceutical 🌀@Bours_Sky
افزایش سرمایه دبالک
تاریخ | نوع افزایش سرمایه | درصد افزایش سرمایه |
---|---|---|
1403/10/19 | آورده نقدی | 98% |
1402/08/09 | سود انباشته | 19% |
1401/05/08 | آورده نقدی | 48% |
1400/06/16 | آورده نقدی | 41% |
1398/04/13 | آورده نقدی | 118% |
تقسیم سود دبالک
تاریخ | مقدار سود | درصد تقسیم سود |
---|---|---|
1404/03/04 | 13 | 10.48% |
1403/02/16 | 760 | 75.4% |
1402/01/30 | 670 | 76.75% |
1401/02/10 | 650 | 85.19% |
1399/12/27 | 590 | 87.8% |
مجامع دبالک
تاریخ | نوع مجامع |
---|---|
1404/04/22 | آگهی دعوت به مجمع عمومی فوق العاده دوره 12 ماهه منتهی به 1404/09/30 |
1404/04/02 | آگهی دعوت به مجمع عمومی فوق العاده دوره 12 ماهه منتهی به 1404/09/30 |
1404/04/02 | لغو آگهی (اطلاعیه) دعوت به مجمع عمومی |
1404/03/04 | آگهی دعوت به مجمع عمومی عادی سالیانه نوبت دوم دوره 12 ماهه منتهی به 1403/09/30 |
1404/01/31 | آگهی دعوت به مجمع عمومی عادی سالیانه دوره 12 ماهه منتهی به 1403/09/30 |
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.